About Malin

Malin Delling's practice focuses on representing public and private companies and financial institutions in connection with securities offerings, mergers and acquisitions, and general corporate matters. Her experience includes initial public offerings, secondary offerings, shelf registration statements, special purpose acquisition companies (SPACs) and domestic and cross-border mergers and acquisitions.

View full bio

Experience

  • Seabridge Gold – $105.2 Million Follow-on Offering

    • Seabridge Gold – $105.2 Million Follow-on Offering

    September 4, 2022

    Cooley advised the underwriters on Seabridge Gold’s $105.2 million follow-on offering. Seabridge Gold is a development-stage company involved in the evaluation, acquisition, exploration and development of gold properties sited in North America. Partner Daniel Goldberg led the Cooley team.

    Related contacts

    Daniel I. Goldberg
    Partner, New York
    Malin Delling
    Special Counsel, Los Angeles

    Related Practices & Industries

    Capital Markets

  • Crinetics Pharmaceuticals – $125 Million Follow-On Offering

    • Crinetics Pharmaceuticals – $125 Million Follow-On Offering

    July 8, 2022

    Cooley advised the underwriters on Crinetics Pharmaceuticals’ $125 million follow-on offering of 5,625,563 shares of common stock at a price to the public of $22.22 per share. Crinetics is a clinical-stage pharmaceutical company developing and commercializing novel therapeutics for rare endocrine diseases and endocrine-related tumors. Partners Daniel Goldberg and Kristin VanderPas led the Cooley team.

    Related contacts

    Daniel I. Goldberg
    Partner, New York
    Kristin VanderPas
    Partner, San Francisco
    Malin Delling
    Special Counsel, Los Angeles
    Madison (JJ) Meng
    Associate, San Francisco

    Related Practices & Industries

    Capital Markets
    Life Sciences and Healthcare
    Healthcare

  • Crinetics Pharmaceuticals – $75 Million Follow-on Offering

    • Crinetics Pharmaceuticals – $75 Million Follow-on Offering

    April 8, 2021

    Cooley advised the underwriters on Crinetics Pharmaceuticals’ $75 million follow-on offering, with SVB Leerink acting as sole bookrunning manager. Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Partner Daniel Goldberg led the Cooley team.

    Related contacts

    Daniel I. Goldberg
    Partner, New York
    Malin Delling
    Special Counsel, Los Angeles

    Related Practices & Industries

    Capital Markets
    Life Sciences and Healthcare
    Healthcare

  • GameStop – $1.1 Billion At-the-Market Offering

    • GameStop – $1.1 Billion At-the-Market Offering

    April 6, 2021

    Cooley advised Jefferies on GameStop’ at-the-market offering where GameStop ultimately sold 5,000,000 shares of common stock and generated aggregate gross proceeds of approximately $1.1 billion. GameStop is a multichannel video game, consumer electronics and services retailer in the US. Partners Daniel Goldberg and Josh Kaufman led the Cooley team.

    Related contacts

    Daniel I. Goldberg
    Partner, New York
    Malin Delling
    Special Counsel, Los Angeles

    Related Practices & Industries

    Capital Markets
    Technology

  • Global Medical REIT – $114.7 Million Follow-on Offering

    • Global Medical REIT – $114.7 Million Follow-on Offering

    March 17, 2021

    Cooley advised the underwriters on Global Medical REIT’s $114.7 million follow-on offering, with J.P. Morgan, BMO Capital Markets, Stifel, Wells Fargo Securities and Baird acting as joint bookrunning managers. Global Medical REIT is a real estate investment trust in the healthcare sector. Partners Daniel Goldberg and Josh Kaufman led the Cooley team.

    Related contacts

    Daniel I. Goldberg
    Partner, New York
    Malin Delling
    Special Counsel, Los Angeles

    Related Practices & Industries

    Capital Markets

Admissions and credentials

  • California

This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as "Cooley"). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction, and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. When advising companies, our attorney-client relationship is with the company, not with any individual. This content may have been generated with the assistance of artificial intelligence (Al) in accordance with our Al Principles, may be considered Attorney Advertising and is subject to our legal notices.